Table 2.
Univariable | Multivariate | |||
---|---|---|---|---|
P | HR (95%CI) | P | HR (95%CI) | |
Model 1 | ||||
Age (≤65 vs. >65) | 0.962 | 1.010(0.550,1.870) | 0.709 | 0.884(0.464,1.685) |
Gender (male vs. female) | 0.119 | 1.650(0.879,3.090) | 0.341 | 1.478(0.662,3.299) |
Histology subtype (SCC vs. ADC) | 0.394 | 1.270(0.735,2.190) | 0.944 | 0.976(0.493,1.933) |
Pathologic stage (IIIA vs. IIB) | 0.064 | 1.720(0.969,3.060) | 0.134 | 1.562(0.871,2.799) |
Pathologic stage (IIIB vs. IIB) | 0.145 | 2.480(0.731,8.430) | 0.167 | 2.423(0.691,8.496) |
high TC-CD4+Tcon density | 0.048 | 3.268(1.011,10.560) | 0.053 | 3.455(0.986,12.107) |
high IM-CD4+Treg density | 0.035 | 1.916(1.048,3.497) | 0.097 | 1.690(0.910,3.139) |
high IM-CD8+Tdys density | 0.012 | 3.876(1.355,11.050) | 0.025 | 3.536(1.170,10.690) |
Model 2 | ||||
Age (≤65 vs. >65) | 0.962 | 1.010(0.550,1.870) | 0.891 | 1.045(0.558,1.956) |
Gender (male vs. female) | 0.119 | 1.650(0.879,3.090) | 0.373 | 1.407(0.663,2.986) |
Histology subtype (SCC vs. ADC) | 0.394 | 1.270(0.735,2.190) | 0.950 | 1.021(0.530,1.969) |
Pathologic stage (IIIA vs. IIB) | 0.064 | 1.720(0.969,3.060) | 0.154 | 1.532(0.852,2.754) |
Pathologic stage (IIIB vs. IIB) | 0.145 | 2.480(0.731,8.430) | 0.154 | 2.513(0.708,8.912) |
high TC-CD4+Tcon proximity | 0.044 | 1.783 (1.017 ,3.125) | 0.416 | 1.284(0.703,2.347) |
high IM-CD4+Treg proximity | 0.007 | 3.021 (1.344 ,6.757) | 0.012 | 2.884(1.258,6.615) |
Boldface type indicates statistical significance on multivariate analysis. HR=hazard ratio, CI=confidence interval.